$DSS
DSS, INC. Stock $dss

$dss Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000149315223041176 Filed on November 14, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$7.013M	$4.182M
YoY Change	-38.37%	-64.74%
Cost Of Revenue	$7.210M	$6.070M
YoY Change	-26.5%	-46.6%
Gross Profit	-$197.0K	-$1.890M
YoY Change	-112.55%	-482.59%
Gross Profit Margin	-2.81%	-45.19%
Selling, General & Admin	$2.314M	$3.213M
YoY Change	-79.05%	-78.11%
% of Gross Profit
Research & Development	$463.0K	$240.0K
YoY Change	-15.97%	-27.49%
% of Gross Profit
Depreciation & Amortization	$1.056M	$1.500M
YoY Change	-70.45%	-48.74%
% of Gross Profit
Operating Expenses	$4.036M	$9.285M
YoY Change	-69.46%	-64.35%
Operating Profit	-$4.233M	-$5.103M
YoY Change	-63.65%	-64.02%
Interest Expense	-$2.544M	$51.00K
YoY Change	198.24%	-91.58%
% of Operating Profit
Other Income/Expense, Net	$1.535M	-$44.00K
YoY Change	-355.41%	-101.21%
Pretax Income	-$44.47M	-$6.681M
YoY Change	46.62%	-73.06%
Income Tax	-$5.000K
% Of Pretax Income
Net Earnings	-$30.30M	-$4.342M
YoY Change	12.54%	-82.49%
Net Earnings / Revenue	-432.1%	-103.83%
Basic Earnings Per Share		-$0.03
Diluted Earnings Per Share	-$4.32	-$0.03
COMMON SHARES
Basic Shares Outstanding	140.3M shares	140.3M shares
Diluted Shares Outstanding		140.3M shares

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$16.62M	$6.900M
YoY Change	-64.34%	-69.8%
Cash & Equivalents	$6.615M	$6.897M
Short-Term Investments	$10.00M
Other Short-Term Assets	$52.43M	$1.200M
YoY Change	2984.35%	-58.59%
Inventory	$2.819M	$3.930M
Prepaid Expenses
Receivables	$3.994M	$3.136M
Other Receivables	$8.772M	$9.300M
Total Short-Term Assets	$74.63M	$24.40M
YoY Change	55.51%	-56.16%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.417M	$12.35M
YoY Change	-52.08%	-23.12%
Goodwill	$26.86M	$57.88M
YoY Change	-55.91%	2.25%
Intangibles
YoY Change
Long-Term Investments	$128.0K	$134.0K
YoY Change	-20.99%	-89.89%
Other Assets	$97.00K	$246.0K
YoY Change	-96.41%	-82.34%
Total Long-Term Assets	$78.56M	$172.1M
YoY Change	-60.9%	-17.72%
TOTAL ASSETS
Total Short-Term Assets	$74.63M	$24.40M
Total Long-Term Assets	$78.56M	$172.1M
Total Assets	$153.2M	$196.6M
YoY Change	-38.46%	-25.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.654M	$2.924M
YoY Change	-38.21%	-27.77%
Accrued Expenses	$3.198M	$3.500M
YoY Change	-84.12%	-71.88%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$47.78M	$46.64M
YoY Change	1.3%	598.17%
Total Short-Term Liabilities	$55.61M	$53.47M
YoY Change	-24.53%	126.86%
LONG-TERM LIABILITIES
Long-Term Debt	$7.451M	$7.747M
YoY Change	-26.81%	-84.56%
Other Long-Term Liabilities		$507.0K
YoY Change		0.0%
Total Long-Term Liabilities	$7.451M	$8.254M
YoY Change	-30.29%	-83.71%
TOTAL LIABILITIES
Total Short-Term Liabilities	$55.61M	$53.47M
Total Long-Term Liabilities	$7.451M	$8.254M
Total Liabilities	$63.06M	$61.73M
YoY Change	-25.26%	-16.86%
SHAREHOLDERS EQUITY
Retained Earnings	-$256.2M	-$225.9M
YoY Change	31.82%	34.92%
Common Stock	$140.0K	$2.804M
YoY Change	-94.96%	0.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$63.93M	$94.30M
YoY Change
Total Liabilities & Shareholders Equity	$153.2M	$196.6M
YoY Change	-38.46%	-25.8%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	-$30.30M	-$4.342M
YoY Change	12.54%	-82.49%
Depreciation, Depletion And Amortization	$1.056M	$1.500M
YoY Change	-70.45%	-48.74%
Cash From Operating Activities	$1.846M	-$1.320M
YoY Change	-149.86%	-85.81%
INVESTING ACTIVITIES
Capital Expenditures	$138.0K	$180.0K
YoY Change	-89.16%	-132.55%
Acquisitions
YoY Change
Other Investing Activities	-$2.806M	-$1.310M
YoY Change	-350.54%	-87.93%
Cash From Investing Activities	-$2.954M	-$1.490M
YoY Change	1830.72%	-86.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	823.0K	-320.0K
YoY Change	174.33%	-18.37%
NET CHANGE
Cash From Operating Activities	1.846M	-1.320M
Cash From Investing Activities	-2.954M	-1.490M
Cash From Financing Activities	823.0K	-320.0K
Net Change In Cash	-285.0K	-3.130M
YoY Change	-91.98%	-85.17%
FREE CASH FLOW
Cash From Operating Activities	$1.846M	-$1.320M
Capital Expenditures	$138.0K	$180.0K
Free Cash Flow	$1.708M	-$1.500M
YoY Change	-134.33%	-82.86%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0000771999
CY2023Q3	us-gaap	Dividend Income Operating DividendIncomeOperating		usd
CY2022Q3	us-gaap	Dividend Income Operating DividendIncomeOperating		usd
	us-gaap	Dividend Income Operating DividendIncomeOperating		usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q3	DSS	Provision For Loan Losses ProvisionForLoanLosses		usd
	DSS	Provision For Loan Losses ProvisionForLoanLosses		usd
CY2022Q3	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges		usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	DSS	Gain Loss On Allowance For Obsolescence Of Inventory GainLossOnAllowanceForObsolescenceOfInventory		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	DSS	Payments To Acquire Real Estates PaymentsToAcquireRealEstates		usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities		usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities		usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	DSS	Notes Receivable Converted To Equity Investments NotesReceivableConvertedToEquityInvestments		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	DSS	Shares Issued For Acquisition Of Notes Receivable SharesIssuedForAcquisitionOfNotesReceivable		usd
	DSS	Right Of Use Asset Addition RightOfUseAssetAddition		usd
CY2023Q3	DSS	Revenue On Commission Income RevenueOnCommissionIncome		usd
CY2022Q3	DSS	Revenue On Commission Income RevenueOnCommissionIncome		usd
	DSS	Revenue On Commission Income RevenueOnCommissionIncome		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-32146
	dei	Entity Registrant Name EntityRegistrantName	DSS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NY
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	16-1229730
	dei	Entity Address Address Line1 EntityAddressAddressLine1	275 Wiregrass Pkwy
	dei	Entity Address City Or Town EntityAddressCityOrTown	West Henrietta
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	14586
	dei	City Area Code CityAreaCode	(585)
	dei	Local Phone Number LocalPhoneNumber	325-3610
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
	dei	Security12b Title Security12bTitle	Common Stock, $0.02 par value per share
	dei	Trading Symbol TradingSymbol	DSS
	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	140264250	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6897000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19290000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3136000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7564000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	3930000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	7721000	usd
CY2023Q3	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	9225000	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	11719000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1215000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1700000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	24403000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	47994000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12351000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13391000	usd
CY2023Q3	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	53482000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	55029000	usd
CY2023Q3	us-gaap	Other Investments OtherInvestments	1163000	usd
CY2022Q4	us-gaap	Other Investments OtherInvestments	1534000	usd
CY2023Q3	us-gaap	Equity Method Investments EquityMethodInvestments	134000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	162000	usd
CY2023Q3	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	11064000	usd
CY2022Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	27307000	usd
CY2023Q3	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	138000	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	922000	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	246000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2699000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7470000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8219000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	57880000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	60919000	usd
CY2023Q3	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	28220000	usd
CY2022Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	30740000	usd
CY2023Q3	us-gaap	Assets Assets	196551000	usd
CY2022Q4	us-gaap	Assets Assets	248916000	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2924000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5914000	usd
CY2023Q3	DSS	Accrued Expenses And Deferred Revenue Current AccruedExpensesAndDeferredRevenueCurrent	2701000	usd
CY2022Q4	DSS	Accrued Expenses And Deferred Revenue Current AccruedExpensesAndDeferredRevenueCurrent	19341000	usd
CY2023Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	396000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	477000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	813000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	796000	usd
CY2023Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	46638000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	47161000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	53472000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	73689000	usd
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	7747000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	10181000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7040000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7820000	usd
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	507000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	507000	usd
CY2023Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	38000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	38000	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.02
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.02
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	140264250	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	140264250	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	139017172	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	139017172	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	2804000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2779000	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	317369000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	317126000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-225873000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-194343000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	94300000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	125562000	usd
CY2023Q3	us-gaap	Minority Interest MinorityInterest	33447000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	31119000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	127747000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	156681000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	196551000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	248916000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4182000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11862000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	23245000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35927000	usd
CY2023Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	6072000	usd
CY2022Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	11933000	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	19437000	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	29658000	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3213000	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	14677000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	21036000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	40316000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	9285000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	26610000	usd
	us-gaap	Operating Expenses OperatingExpenses	40473000	usd
	us-gaap	Operating Expenses OperatingExpenses	69974000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5103000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-14748000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-17228000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-34047000	usd
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	682000	usd
CY2022Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	319000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1220000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	613000	usd
	us-gaap	Dividend Income Operating DividendIncomeOperating	12000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-44000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3627000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	139000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4203000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	51000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	42000	usd
	us-gaap	Interest Expense InterestExpense	438000	usd
	us-gaap	Interest Expense InterestExpense	100000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	110000	usd
CY2023Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-6000	usd
CY2022Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	344000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-28000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	134000	usd
CY2023Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	301000	usd
CY2022Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	-14302000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-30490000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-10479000	usd
CY2023Q3	DSS	Provision For Loan Losses ProvisionForLoanLosses	-1179000	usd
	DSS	Provision For Loan Losses ProvisionForLoanLosses	-4936000	usd
CY2023Q3	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-1281000	usd
	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-1281000	usd
	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	405000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6681000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-24802000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-53030000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-39161000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-6681000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-24802000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-53039000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-39161000	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2339000	usd
CY2022Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-4587000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2736000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-6247000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-4342000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-20215000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-50303000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-32914000	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.36
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	140264250	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	134893360	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	139809113	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	102390079	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	140264250	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	134893360	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	139809113	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	102390079	shares
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-53039000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-39161000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4150000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9351000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	4000	usd
	DSS	Equity Method Investments Gain Loss EquityMethodInvestmentsGainLoss	-28000	usd
	DSS	Equity Method Investments Gain Loss EquityMethodInvestmentsGainLoss	134000	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-30490000	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-10479000	usd
	DSS	Gain Loss On Allowance For Obsolescence Of Inventory GainLossOnAllowanceForObsolescenceOfInventory	-326000	usd
	DSS	Change In Right Of Use Assets ChangeInRightOfUseAssets	-749000	usd
	DSS	Change In Right Of Use Assets ChangeInRightOfUseAssets	7961000	usd
	DSS	Change In Right Of Useliabilities ChangeInRightOfUseliabilities	763000	usd
	DSS	Change In Right Of Useliabilities ChangeInRightOfUseliabilities	-8297000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	110000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-1281000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	405000	usd
	DSS	Impairment Of Notes Receivable And Other Investments ImpairmentOfNotesReceivableAndOtherInvestments	4936000	usd
	DSS	Impairment Of Notes Receivable And Other Investments ImpairmentOfNotesReceivableAndOtherInvestments	1899000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2520000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3316000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-4368000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	728000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-323000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-568000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-2448000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	904000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2896000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2128000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-15549000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-3205000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-81000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-379000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-21035000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-23251000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	679000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1349000	usd
	DSS	Payments To Acquire Real Estates PaymentsToAcquireRealEstates	689000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	14254000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	215000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	2557000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	11330000	usd
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	400000	usd
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	4687000	usd
	us-gaap	Proceeds From Sale Of Notes Receivable ProceedsFromSaleOfNotesReceivable	1419000	usd
	us-gaap	Proceeds From Sale Of Notes Receivable ProceedsFromSaleOfNotesReceivable	786000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	180000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	11885000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-17816000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	4056000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	561000	usd
	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	813000	usd
	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	6360000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1518000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3243000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7317000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations	-12393000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations	-33750000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19290000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	56595000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6897000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	22845000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	156681000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	268000	usd
	DSS	Stock Issued During Period Value Deconsolidation StockIssuedDuringPeriodValueDeconsolidation	23837000	usd
	us-gaap	Profit Loss ProfitLoss	-53039000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	127747000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	198185000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	17405000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	6220000	usd
	us-gaap	Profit Loss ProfitLoss	-39161000	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	182649000	usd
CY2023Q2	DSS	Deconsolidation On Loss Before Income Taxes DeconsolidationOnLossBeforeIncomeTaxes	29196000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_848_eus-gaap--UseOfEstimates_zNEtaxYmmIii" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zSbDjJrLi4Y9">Use of Estimates</span> - </i></b>The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires the Company to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from these estimates. On an ongoing basis, the Company evaluates its estimates, including those related to the accounts receivable, convertible notes receivable, inventory, fair values of investments, intangible assets and goodwill, useful lives of intangible assets and property and equipment, fair values of options and warrants to purchase the Company’s common stock, preferred stock, deferred revenue and income taxes, among others. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_z38QWunLgh63" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span><span id="xdx_867_zqac7SKLgDr7">Concentration of Credit Risk</span></span> </i></b><i>-</i> The Company maintains its cash in bank deposit accounts, which at times may exceed federally insured limits. The Company believes it is not exposed to any significant credit risk as a result of any non-performance by the financial institutions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 60pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2023, two customers accounted for approximately <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230930__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zY7Sj1hxORB1">21% </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230930__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_znWIDe1STK7e">7% </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of our consolidated revenue and these two customers approximately <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230930__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z5FZSX5ofFW2">32% </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230930__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zsvPDzxWv8B6">15% </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of our consolidated trade accounts receivable balance. As of December 31, 2022, two customers accounted for approximately <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zTHSuWfQyPs3">14% </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z695LioPqqx5">6% </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of our consolidated revenue and these two customers approximately <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zTGiyxjlHAxb">36% </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zCoio0ZLrJ2l">17% </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of our consolidated trade accounts receivable balance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2706000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	29000	usd
CY2023Q3	us-gaap	Cash Cash	6900000	usd
CY2023Q3	us-gaap	Cash Cash	6900000	usd
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	11100000	usd
	DSS	Principal And Interest On Note Receivable PrincipalAndInterestOnNoteReceivable	6300000	usd
CY2023Q3	us-gaap	Inventory Adjustments InventoryAdjustments	57000	usd
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments	742000	usd
CY2023Q3	us-gaap	Cash Cash	6900000	usd
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	11100000	usd
	DSS	Principal And Interest On Note Receivable PrincipalAndInterestOnNoteReceivable	6300000	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2894000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	6779000	usd
CY2023Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	79000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	403000	usd
CY2023Q3	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1014000	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1281000	usd
CY2023Q3	us-gaap	Inventory Gross InventoryGross	3987000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	8463000	usd
CY2023Q3	us-gaap	Inventory Adjustments InventoryAdjustments	57000	usd
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments	742000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	3930000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	7721000	usd
CY2023Q3	DSS	Redeemable Preferred Stoc Per Share RedeemablePreferredStocPerShare	1000
	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	26000000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-8039000	usd
CY2023Q3	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	17961000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	6897000	usd
CY2023Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	11064000	usd
CY2022	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	59894000	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-3659000	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	46776000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	19290000	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	27307000	usd
CY2022Q4	us-gaap	Investments Investments	179000	usd
CY2022	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	49076804	usd
CY2022	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-61680088	usd
CY2022	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-0.55
CY2022	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-0.55
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	46952000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	859000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	901000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	947000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	1200000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	3526000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1275000	usd
	us-gaap	Interest Paid Net InterestPaidNet	1907000	usd
	DSS	Notes Receivable Converted To Equity Investments NotesReceivableConvertedToEquityInvestments	1940000	usd
	us-gaap	Stock Issued1 StockIssued1	7169000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	861000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	839000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	808000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	824000	usd
CY2023Q3	DSS	Lessee Operating Lease Liability Payments Due After Year Six LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix	4916000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	9523000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1670000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	7853000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	813000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7040000	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P13Y3M18D
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.043	pure
CY2023Q3	DSS	Cash Paid For Leases CashPaidForLeases	319000	usd
	DSS	Cash Paid For Leases CashPaidForLeases	948000	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	17570948	shares
	us-gaap	Interest Paid Net InterestPaidNet	3432000	usd
	DSS	Shares Issued For Acquisition Of Notes Receivable SharesIssuedForAcquisitionOfNotesReceivable	8717000	usd
	DSS	Right Of Use Asset Addition RightOfUseAssetAddition	9895000	usd
	DSS	Shares Issued In Lieu Of Bonus Cash SharesIssuedInLieuOfBonusCash	268000	usd
	DSS	Shares Issued In Lieu Of Bonus Cash SharesIssuedInLieuOfBonusCash	6216000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4182000	usd
CY2023Q3	DSS	Interest Expenses InterestExpenses	51000	usd
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	682000	usd
CY2023Q3	DSS	Net Income Loss From Continuing Operations NetIncomeLossFromContinuingOperations	-6681000	usd
CY2023Q3	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	67000	usd
CY2023Q3	DSS	Identifiable Assets IdentifiableAssets	196551000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11862000	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2927000	usd
CY2022Q3	DSS	Interest Expenses InterestExpenses	606000	usd
CY2022Q3	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	319000	usd
CY2022Q3	DSS	Net Income Loss From Continuing Operations NetIncomeLossFromContinuingOperations	-24802000	usd
CY2022Q3	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	373000	usd
CY2022Q3	DSS	Identifiable Assets IdentifiableAssets	264880000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	23245000	usd
	DSS	Interest Expenses InterestExpenses	438000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1220000	usd
	DSS	Net Income Loss From Continuing Operations NetIncomeLossFromContinuingOperations	-53039000	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	679000	usd
	DSS	Identifiable Assets IdentifiableAssets	196551000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35927000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	9351000	usd
	DSS	Interest Expenses InterestExpenses	2105000	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	4000	usd
	DSS	Net Income Loss From Continuing Operations NetIncomeLossFromContinuingOperations	-39161000	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	1349000	usd
	DSS	Identifiable Assets IdentifiableAssets	264880000	usd
CY2023Q3	DSS	Aggregate Value Of Printed Products AggregateValueOfPrintedProducts	3315000	usd
CY2022Q3	DSS	Aggregate Value Of Printed Products AggregateValueOfPrintedProducts	5032000	usd
	DSS	Aggregate Value Of Printed Products AggregateValueOfPrintedProducts	12976000	usd
	DSS	Aggregate Value Of Printed Products AggregateValueOfPrintedProducts	12650000	usd
CY2023Q3	DSS	Revenue On Direct Marketing RevenueOnDirectMarketing	523000	usd
CY2022Q3	DSS	Revenue On Direct Marketing RevenueOnDirectMarketing	4937000	usd
	DSS	Revenue On Direct Marketing RevenueOnDirectMarketing	6088000	usd
	DSS	Revenue On Direct Marketing RevenueOnDirectMarketing	17939000	usd
CY2023Q3	DSS	Revenue On Securities RevenueOnSecurities	236000	usd
CY2022Q3	DSS	Revenue On Securities RevenueOnSecurities	1485000	usd
	DSS	Revenue On Securities RevenueOnSecurities	3464000	usd
	DSS	Revenue On Securities RevenueOnSecurities	4656000	usd
	DSS	Revenue On Net Investment Income RevenueOnNetInvestmentIncome	422000	usd
	DSS	Revenue On Net Investment Income RevenueOnNetInvestmentIncome	644000	usd
	DSS	Revenue On Commission Income RevenueOnCommissionIncome	295000	usd
CY2023Q3	DSS	Revenue On Net Investment Income RevenueOnNetInvestmentIncome	108000	usd
CY2022Q3	DSS	Revenue On Net Investment Income RevenueOnNetInvestmentIncome	370000	usd

Files In Submission

Name	View Source	Status
dss-20230930_def.xml	Edgar Link	unprocessable
0001493152-23-041176-index-headers.html	Edgar Link	pending
0001493152-23-041176-index.html	Edgar Link	pending
0001493152-23-041176.txt	Edgar Link	pending
0001493152-23-041176-xbrl.zip	Edgar Link	pending
dss-20230930.xsd	Edgar Link	pending
dss_001.jpg	Edgar Link	pending
ex10-1.htm	Edgar Link	pending
ex10-1_001.jpg	Edgar Link	pending
ex10-1_002.jpg	Edgar Link	pending
ex10-1_003.jpg	Edgar Link	pending
ex10-1_004.jpg	Edgar Link	pending
ex10-1_005.jpg	Edgar Link	pending
ex10-1_006.jpg	Edgar Link	pending
ex10-1_007.jpg	Edgar Link	pending
ex10-1_008.jpg	Edgar Link	pending
ex10-1_009.jpg	Edgar Link	pending
ex10-2.htm	Edgar Link	pending
ex10-2_001.jpg	Edgar Link	pending
ex10-2_002.jpg	Edgar Link	pending
ex10-2_003.jpg	Edgar Link	pending
ex10-2_004.jpg	Edgar Link	pending
ex10-2_005.jpg	Edgar Link	pending
ex10-2_006.jpg	Edgar Link	pending
ex10-2_007.jpg	Edgar Link	pending
ex10-2_008.jpg	Edgar Link	pending
ex10-2_009.jpg	Edgar Link	pending
ex10-2_010.jpg	Edgar Link	pending
ex10-2_011.jpg	Edgar Link	pending
ex10-2_012.jpg	Edgar Link	pending
ex10-2_013.jpg	Edgar Link	pending
ex10-2_014.jpg	Edgar Link	pending
ex10-2_015.jpg	Edgar Link	pending
ex10-2_016.jpg	Edgar Link	pending
ex10-2_017.jpg	Edgar Link	pending
ex10-2_018.jpg	Edgar Link	pending
ex10-2_019.jpg	Edgar Link	pending
ex10-2_020.jpg	Edgar Link	pending
dss-20230930_pre.xml	Edgar Link	unprocessable
ex10-2_021.jpg	Edgar Link	pending
ex10-2_022.jpg	Edgar Link	pending
ex10-2_023.jpg	Edgar Link	pending
ex10-2_024.jpg	Edgar Link	pending
ex10-2_025.jpg	Edgar Link	pending
ex10-2_026.jpg	Edgar Link	pending
ex10-2_027.jpg	Edgar Link	pending
ex10-2_028.jpg	Edgar Link	pending
ex10-2_029.jpg	Edgar Link	pending
ex10-2_030.jpg	Edgar Link	pending
ex3-1.htm	Edgar Link	pending
ex3-1_001.jpg	Edgar Link	pending
ex3-1_002.jpg	Edgar Link	pending
ex3-1_003.jpg	Edgar Link	pending
ex3-1_004.jpg	Edgar Link	pending
ex3-1_005.jpg	Edgar Link	pending
ex3-1_006.jpg	Edgar Link	pending
ex3-1_007.jpg	Edgar Link	pending
ex3-1_008.jpg	Edgar Link	pending
ex3-1_009.jpg	Edgar Link	pending
ex3-1_010.jpg	Edgar Link	pending
ex3-1_011.jpg	Edgar Link	pending
ex3-1_012.jpg	Edgar Link	pending
ex3-1_013.jpg	Edgar Link	pending
ex3-1_014.jpg	Edgar Link	pending
ex3-1_015.jpg	Edgar Link	pending
ex3-1_016.jpg	Edgar Link	pending
ex3-1_017.jpg	Edgar Link	pending
ex3-1_018.jpg	Edgar Link	pending
ex3-1_019.jpg	Edgar Link	pending
ex3-1_020.jpg	Edgar Link	pending
ex3-1_021.jpg	Edgar Link	pending
ex3-1_022.jpg	Edgar Link	pending
ex3-1_023.jpg	Edgar Link	pending
ex3-1_024.jpg	Edgar Link	pending
ex3-1_025.jpg	Edgar Link	pending
ex3-1_026.jpg	Edgar Link	pending
ex3-1_027.jpg	Edgar Link	pending
ex3-1_028.jpg	Edgar Link	pending
ex3-1_029.jpg	Edgar Link	pending
ex3-1_030.jpg	Edgar Link	pending
ex3-1_031.jpg	Edgar Link	pending
ex3-1_032.jpg	Edgar Link	pending
ex3-1_033.jpg	Edgar Link	pending
ex3-1_034.jpg	Edgar Link	pending
ex3-1_035.jpg	Edgar Link	pending
ex3-1_036.jpg	Edgar Link	pending
ex3-1_037.jpg	Edgar Link	pending
ex3-1_038.jpg	Edgar Link	pending
ex3-1_039.jpg	Edgar Link	pending
ex3-1_040.jpg	Edgar Link	pending
ex3-1_041.jpg	Edgar Link	pending
ex3-1_042.jpg	Edgar Link	pending
ex3-1_043.jpg	Edgar Link	pending
ex3-1_044.jpg	Edgar Link	pending
ex3-1_045.jpg	Edgar Link	pending
ex3-1_046.jpg	Edgar Link	pending
ex3-1_047.jpg	Edgar Link	pending
ex3-1_048.jpg	Edgar Link	pending
ex3-1_049.jpg	Edgar Link	pending
ex3-1_050.jpg	Edgar Link	pending
ex3-1_051.jpg	Edgar Link	pending
ex3-1_052.jpg	Edgar Link	pending
ex3-1_053.jpg	Edgar Link	pending
ex3-1_054.jpg	Edgar Link	pending
ex3-1_055.jpg	Edgar Link	pending
ex3-1_056.jpg	Edgar Link	pending
ex3-1_057.jpg	Edgar Link	pending
ex3-1_058.jpg	Edgar Link	pending
ex3-1_059.jpg	Edgar Link	pending
ex3-1_060.jpg	Edgar Link	pending
ex3-1_061.jpg	Edgar Link	pending
ex3-1_062.jpg	Edgar Link	pending
ex3-1_063.jpg	Edgar Link	pending
ex3-2.htm	Edgar Link	pending
ex3-3.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
dss-20230930_cal.xml	Edgar Link	unprocessable
dss-20230930_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DSS
DSS, INC. Stock $dss

2023 Q4 Form 10-Q Financial Statement

#000149315223041176 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DSS DSS, INC. Stock $dss

2023 Q4 Form 10-Q Financial Statement

#000149315223041176 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DSS
DSS, INC. Stock $dss